Singapore, July 23 -- Cenra Healthcare, the sales and marketing arm of Cenra Inc., has announced the deepening of its long-standing collaboration with the global pharmaceutical company Dr. Reddy's Laboratories. Since the partnership began in 2020, the two companies have worked closely to introduce a diverse range of high-quality generic drugs and innovative formulations to patients inTaiwan, with a shared commitment to broadening access to affordable and clinically valuable treatments.

Over the past five years, Cenra Healthcare and Dr Reddy's have successfully introduced a number of key therapies in the field of oncology, including chemotherapy agents, hormone therapies, and targeted treatments for prostate cancer, breast cancer, ovarian...